Search

everythinglearnresearchcommunity

for

Search:↓

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

JAK inhibitors show promise for treating various skin diseases.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Linoleic acid is important for healthy skin and hair.

Wild strawberry waste extract can be a sustainable cosmetic ingredient for treating acne and hair loss.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.